Nanoform sets new near-term business target for 2021 and 2022
Insider information Nanoform Finland Plc February 26, 2021 08:05 a.m. Finnish time / 07:05 a.m. Swedish time Nanoform sets new near-term business target for 2021 and 2022 Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced a new near-term business target. In 2021 and 2022 the company hereby targets “At least 3 new non-GMP lines in 2021 and 2 new GMP lines in 2022”. Nanoform also re-iterated it’s other near-term target, announced January 4 (2021), of “at least a dozen new non-GMP customer projects and